News

11 January 2021

4 Ways Johnson & Johnson Advanced Much-Needed Healthcare Innovations Amid the Pandemic

Read full story

5 January 2021

Aro Biotherapeutics Announces $88 Million Series A Financing to Advance Development of Centyrin-Targeted Genetic Medicines

Read full story

9 January 2019

Johnson & Johnson Innovation Awards Bloomlife the First 1000 Days QuickFire Challenge

Read full story

3 January 2019

Locus Biosciences Enters a Collaboration and License Agreement with Johnson & Johnson Innovation to develop CRISPR-Cas3 Bacteriophage Therapeutics

Read full story